Controlled formation of the anhydrous polymorph of ciprofloxacin crystals embedded within chitosan scaffolds: study of the kinetic release dependence on crystal size

被引:15
作者
Aranaz, I. [1 ]
Gutierrez, M. C. [1 ]
Yuste, L. [2 ]
Rojo, F. [2 ]
Ferrer, M. L. [1 ]
del Monte, F. [1 ]
机构
[1] Inst Ciencia Mat, Madrid 28049, Spain
[2] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain
关键词
NANOPARTICLES; HYDROCHLORIDE; POLYMERS; SYSTEMS; GROWTH; CARBON; DRUG; FORM;
D O I
10.1039/b813156b
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
This work describes a simple procedure for preparation of chitosan (CHI) scaffolds containing ciprofloxacin (CFX) anhydrous crystals. The capability of CHI scaffolds to control the CFX crystal size and to preserve the anhydrous crystal habit even after long term storage was useful for the development of drug delivery systems (e.g., CFX/CHI scaffolds) exhibiting a novel way to control the kinetic release, that is, by the solubility/hydration ratio of CFX anhydrous crystals depending on their crystal size rather than by typical mechanisms based on swelling, hydration and/or erosion of the polymer acting as carrier.
引用
收藏
页码:1576 / 1582
页数:7
相关论文
共 39 条
[1]   Multiwall carbon nanotube scaffolds for tissue engineering purposes [J].
Abarrategi, Ander ;
Gutierrez, Maria C. ;
Moreno-Vicente, Carolina ;
Hortiguela, Maria J. ;
Ramos, Viviana ;
Lopez-Lacomba, Jose L. ;
Ferrer, Maria L. ;
del Monte, Francisco .
BIOMATERIALS, 2008, 29 (01) :94-102
[2]   Factors involved in the formation of amorphous and crystalline calcium carbonate: A study of an ascidian skeleton [J].
Aizenberg, J ;
Lambert, G ;
Weiner, S ;
Addadi, L .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (01) :32-39
[3]  
[Anonymous], 2006, Polymorphism: In thePharmaceutical Industry
[4]  
[Anonymous], 1897, Z. f.ur. Physikalische Chem. Bd, DOI DOI 10.1515/ZPCH-1897-2233
[5]   Control of crystal phase switching and orientation by soluble mollusc-shell proteins [J].
Belcher, AM ;
Wu, XH ;
Christensen, RJ ;
Hansma, PK ;
Stucky, GD ;
Morse, DE .
NATURE, 1996, 381 (6577) :56-58
[6]  
Bernstein J., 2002, POLYMORPHISM MOL CRY
[7]  
Byrn S.R., 1999, Solid State Chemistry of Drugs, VSecond
[8]   Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development [J].
Chemburkar, SR ;
Bauer, J ;
Deming, K ;
Spiwek, H ;
Patel, K ;
Morris, J ;
Henry, R ;
Spanton, S ;
Dziki, W ;
Porter, W ;
Quick, J ;
Bauer, P ;
Donaubauer, J ;
Narayanan, BA ;
Soldani, M ;
Riley, D ;
McFarland, K .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2000, 4 (05) :413-417
[9]   Selective crystal growth of the anhydrous and monohydrate forms of theophylline on self-assembled monolayers [J].
Cox, Jason R. ;
Dabros, Marta ;
Shaffer, Jeanne A. ;
Thalladi, Venkat R. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2007, 46 (12) :1988-1991
[10]   Polymorphism in molecular crystals: Stabilization of a metastable form by conformational mimicry [J].
Davey, RJ ;
Blagden, N ;
Potts, GD ;
Docherty, R .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (07) :1767-1772